157 related articles for article (PubMed ID: 38516689)
1. Clinical role of the long non‑coding RNA, EGFR‑AS1, in patients with cancer: A systematic review and meta‑analysis.
Zhu L; Zhang J; Zhou H; Zhang G; Wang B; Qi H
Oncol Lett; 2024 May; 27(5):199. PubMed ID: 38516689
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors.
Zhou L; Li Z; Shao X; Yang B; Feng J; Xu L; Teng Y
Pathol Res Pract; 2019 Sep; 215(9):152449. PubMed ID: 31378453
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and clinical significance of long non-coding RNA HNF1A-AS1 in solid cancers: A systematic review and meta-analysis.
Zhou X; Fan YH; Wang Y; Liu Y
Medicine (Baltimore); 2019 Dec; 98(49):e18264. PubMed ID: 31804362
[TBL] [Abstract][Full Text] [Related]
4. TP73-AS1 as a predictor of clinicopathological parameters and prognosis in human malignancies: a meta and bioinformatics analysis.
Chen C; Wang J; Feng Y; Liang Y; Huang Y; Zou W
BMC Cancer; 2022 May; 22(1):581. PubMed ID: 35614413
[TBL] [Abstract][Full Text] [Related]
5. The prognostic role of long noncoding RNA CRNDE in cancer patients: a systematic review and meta-analysis.
Wang W; Yuan F; Xu J
Neoplasma; 2019 Jan; 66(1):73-82. PubMed ID: 30509091
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of lncRNA AGAP2-AS1 in cancer patients: A meta-analysis.
Zhong P; Hua H; Chen S; Zhu Z; Xie F
Medicine (Baltimore); 2021 Dec; 100(51):e28425. PubMed ID: 34941192
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value and therapeutic potential of the long noncoding RNA TP73-AS1 in cancers: A systematic review and meta-analysis.
Zhong Y; Zhao M; Yu Y; Li Q; Wang F; Wu P; Zhang W; Miao L
Sci Rep; 2020 Jun; 10(1):9053. PubMed ID: 32493915
[TBL] [Abstract][Full Text] [Related]
8. Clinical value of long noncoding RNA ZEB1 anti-sense1 in cancer patients: A meta-analysis.
Cheng S; Guo S; He H; Kaminga AC; Xu H
Medicine (Baltimore); 2020 Jul; 99(31):e21307. PubMed ID: 32756112
[TBL] [Abstract][Full Text] [Related]
9. The Clinical Prognostic Value of lncRNA SBF2-AS1 in Cancer Patients: A Meta-Analysis.
Wang J; Zhong P; Hua H
Technol Cancer Res Treat; 2021; 20():15330338211004915. PubMed ID: 33906548
[TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
11. Long Non-Coding RNA FOXD2-AS1 Serves as a Potential Prognostic Biomarker for Patients With Cancer: A Meta-Analysis and Database Testing.
Duan F; Li H; Liu W; Zhao J; Yang Z; Zhang J
Am J Med Sci; 2021 Aug; 362(2):173-181. PubMed ID: 34303519
[TBL] [Abstract][Full Text] [Related]
12. The clinical prognostic value of long noncoding RNA HAND2-AS1 in cancer patients: A study based on meta-analysis and TCGA data (PRISMA).
Yan Z; Lu J; Xu X; You Y; Xu J; Xu T
Medicine (Baltimore); 2022 Sep; 101(39):e30789. PubMed ID: 36181101
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of lncRNA FEZF1 antisense RNA 1 over-expression in oncologic outcomes of patients with solid tumors.
Zhang Y; Yang QX; Peng TT; Wang LJ; Xiao GL; Tang SB
Medicine (Baltimore); 2019 Jun; 98(24):e15982. PubMed ID: 31192939
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of long non-coding RNA ZEB1-AS1 in Chinese cancer patients: A Meta-analysis.
Zhou X; Fan YH; Wang Y; Wang F; Liu Y
Medicine (Baltimore); 2019 Apr; 98(17):e15251. PubMed ID: 31027073
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA AFAP1-AS1 is a novel biomarker in various cancers: a systematic review and meta-analysis based on the literature and GEO datasets.
Wang Y; Mo Y; Yang X; Zhou R; Wu Z; He Y; Yang X; Zhong Y; Du Y; Zhou H; Li X; Li Y; Li G; Zeng Z; Guo C; Xiong W
Oncotarget; 2017 Nov; 8(60):102346-102360. PubMed ID: 29254250
[TBL] [Abstract][Full Text] [Related]
16. Upregulated expression of LncRNA nicotinamide nucleotide transhydrogenase antisense RNA 1 is correlated with unfavorable clinical outcomes in cancers.
Zhang C; Ren X; Liu Z; Tu C
BMC Cancer; 2020 Sep; 20(1):879. PubMed ID: 32928135
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of long noncoding RNA ZEB1-AS1 on clinical outcomes in human cancer.
Wu Y; Ding M; Wei S; Wu T; Xu R; Zhu X; Liu H
J Cancer; 2018; 9(20):3690-3698. PubMed ID: 30405838
[No Abstract] [Full Text] [Related]
18. The role of FOXD2-AS1 in cancer: a comprehensive study based on data mining and published articles.
Zhang Y; Liang C; Zhang Y; Wang Z; Li R; Wei Z; Guo J
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33140822
[TBL] [Abstract][Full Text] [Related]
19. The utility of long non-coding RNA ZEB1-AS1 as a prognostic biomarker in human solid tumors: A meta-analysis.
Zuo XL; Cai J; Chen ZQ; Zhang Y; Liang LH; Wang JF; Wang JG; Wu J; Mao JD
Clin Chim Acta; 2018 Oct; 485():14-20. PubMed ID: 29906419
[TBL] [Abstract][Full Text] [Related]
20. The clinicopathological and prognostic value of long non-coding RNA ZEB1-AS1 in solid tumors: A meta-analysis.
Liang C; Liu J; Ge H; Xu Y; Li G; Wu J
Clin Chim Acta; 2018 Sep; 484():91-98. PubMed ID: 29778540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
